The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.42
Bid: 17.42
Ask: 18.08
Change: 0.14 (0.80%)
Spread: 0.66 (3.789%)
Open: 17.42
High: 17.42
Low: 17.42
Prev. Close: 17.61
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notes Publication of Oeko-Institut Report

14 Jun 2016 07:00

RNS Number : 0712B
Nanoco Group PLC
14 June 2016
 

For immediate release

14 June 2016

 

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Notes Publication of Oeko-Institut Report

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, notes publication of the latest report sponsored by the European Commission on the use in Europe of quantum dots that contain the hazardous substance cadmium.

The report, prepared by the Oeko-Institut for the European Commission, is available at the following link: http://rohs.exemptions.oeko.info/fileadmin/user_upload/reports/20160602_Final_Report_RoHS_Pack_10_Cd_QDs_amended.pdf.

The report, entitled Assistance to the Commission on Technological Socio-Economic and Cost-Benefit Assessment Related to Exemptions from the Substance restrictions in Electrical and Electronic Equipment (RoHS Directive), recommends no exemption for the use of cadmium-containing quantum dots in lighting applications and a three year exemption to the Restriction of Hazardous Substances Directive (RoHS) to allow the use of cadmium-containing quantum dots in display products.

The report contains many apparent contradictions and anomalies when compared with the version prepared by the same consultancy and published in 2014. The display recommendation is in conflict with an overwhelming vote last year by Members of the European Parliament to ban the use of cadmium in quantum dots. MEPs voted 618-33 against an exemption for cadmium-containing quantum dots.

The recommendations in the Oeko-Institut report are not legally binding but form part of a lengthy process of consultation during which the report's findings will be evaluated by the European Commission, Member States and the European Parliament. This consultation will need to consider whether the use of cadmium can be justified as, to quote the report, "it is beyond the scientifically based assessment mandate of the exemption evaluation to conclude whether the use of a RoHS restricted substance to enable a certain function or property is an acceptable cost".

Michael Edelman, Nanoco's Chief Executive Officer, commented: "We are studying this report closely and will respond to it as we see appropriate. There is no doubt that the recommendation for a new exemption for displays is retrogressive as cadmium-free quantum dots are in large-scale commercial production and TVs that use cadmium-free quantum dots are widely available. It is difficult to appreciate why the recommendations in this new report contradict the recommendations made by the same consultancy in its 2014 report, particularly in the light of the commercial success of cadmium-free alternatives.

"Of prime importance, and irrespective of European legislation, is that display makers themselves are choosing cadmium-free because of their commitment to developing products with a long-term and sustainable future."

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

 

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has a non-exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGMVMFKGVZZ
Date   Source Headline
16th Jul 20214:41 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSNon-dilutive loan note subscription
5th Jul 20217:30 amRNSDevelopment Agreement
28th Jun 20217:00 amRNSLitigation update and non-dilutive debt facility
10th Jun 202111:33 amRNSBlocklisting Six-Monthly Return
24th May 202112:20 pmRNSHolding(s) in Company
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.